Mechanisms of resistance to topoisomerases poisons

General Pharmacology

Volumn 26, Issue 8, 1995, Pages 1773-1784

  Prost, S ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

cancer treatment; drug resistance; Topoisomerase

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DACTINOMYCIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ELLIPTICINE; ETOPOSIDE; FOSTRIECIN; INTOPLICINE; MERBARONE; SAINTOPIN; SURAMIN; TENIPOSIDE; UNCLASSIFIED DRUG; ENZYME INHIBITOR;

CANCER; CANCER THERAPY; CATALYSIS; CELL FUNCTION; CROSS RESISTANCE; DETOXIFICATION; DNA CONFORMATION; DRUG MECHANISM; DRUG TRANSPORT; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RELAPSE; REVIEW; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE; ENZYME INHIBITORS; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 0029586426     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)00108-5     Document Type: Article

References (88)

1. Identification of an N-terminal domaine of eukaryotic DNA topoisomerase I dispensable for catalytic activity but essential for in vivo function
2. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I
3. Isolation and characterization of a human cDNA clone encoding a novel DNA topoisomerase II homologue from HeLa cells
4. Cell death in health and disease; the biology and regulation of apoptosis
5. Expression of human DNA Topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumour drug camptothecin
6. Suramin is an inhibitor of DNA topoisomerase II in vitro and in chinese hamster fibrosarcoma cells
7. Inhibition of type II topoisomerase by fostriecin
8. Expression of multidrug resistance gene in ovarian carcinomas
9. Expression of a mutant DNA topoisomerase II in CCRFCEM human leukemic cells selected for resistance to etoposide
10. A novel mutant Topoisomerase II-alpha present in VP-16 resistant human melanoma cell line has a deletion of alanine 429
11. Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant chinese hamster ovary cell line
12. Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isoenzymes
13. Thymocyte apoptosis induced by p53-dependant and independant pathways
14. When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs
15. Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis-Evidence for a common mechanism of regulation by phosphorylation
16. Topoisomerase targeting antitumour drugs
17. Single-strand conformational polymorphism analysis of the Mr 170,000 isoenzyme of DNA topoisomerase II in human tumor cells
18. Evidence for a mutant allele of the gene for DNA topoisomerase II in Adriamycin-resistant P388 murine leukemia cells
19. Apoptotic cell death triggered by camptothecin or teniposide-The cell cycle specificity and effects of ionizing radiation
20. Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II
21. DNA topoisomerases from rat liver: physiological variations
22. A phase I study of the Topoisomerase I and II inhibitors topotecan and etoposide
23. Development of a stable Camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content
24. Reduced levels of Topoisomerase II alpha and II beta in a multidrug resistant lung cancer cell line
25. Altered subcellular distribution of Topoisomerase II alpha in a drug- resistant human small lung cancer cell line
26. Induction of ase II alpha in a drug- resistant human small lung cancer cell line
27. Induction of nuclear accumulation of the tumor- suppressor protein p53 by DNA damaging agents
28. DNA topoisomerases
29. P-glycoprotein in human sarcoma: evidence for multidrug resistance
30. Biochemistry of multidrug resistance mediated by the multidrug transporter
31. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs
32. Camptothecin-resistant mutants of chinese hamster ovary cells containing a resistant from of topoisomerase I
33. Intercellular forms of drosophila topoisomerase II detected with monoclonal antibodies
34. In vivo phosphorylation of the 170- kDa form of eukaryote DNA topoisomerase II
35. On the mechanism of topoisomerase I inhibition by camptothecin evidence for binding to an enzyme-DNA complex
36. Identification of a point mutation in the Topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II
37. The role of topoisomerase II α and β in drug resistance
38. Bcl-2 is a inner mitochondrial membrane protein that blocks programmed cell death
39. Topoisomerase II in multiple drug resistance
40. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I
41. Isolation of cDNA clones encoding the beta-isoenzyme of human topoisomerase II and localisation of the gene to chromosome 3p24
42. Human DNA topoisomerase I is encoded by a single-copy gene that maps to chromosome region 20q12-13.2
43. Establishment of a camptothecin analogue (CPT-11) resistant cell line of human non-small cell lung cancer
44. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposite, camptothecin, and other cytotoxic anticancer drugs: A cautionary note
45. Expression of Topoisomerase II alpha and Topoisomerase II beta in Chinese Hamster lung cells resistant to Topoisomerase II inhibitors
46. Detection of topoisomerase I gene mutation in CPT-II resistant lung cancer cells
47. Detoxification mechanisms and tumor cell resistance to anticancer drugs
48. Two independant amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kda form of human topoisomerase II
49. Study of molecular markers of resistance to mAMSA in a human breast cancer cell line
50. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells
51. DNA topoisomerase poison as antitumor drugs
52. p53 is required for radiatio-induced apoptosis in mouse thymocytes
53. p53 status and the efficacy of cancer therapy in vivo
54. Overexpression of human Topoisomerase I in baby hamster kidney cells-Hypersensitivity of clonal isolated to camptothecin
55. Sequencial modifications of topoisomerase I activity in a Camptothecin resistant cell line established by progressive adaptation
56. An overview of membrane, cytosolic and nuclear proteins associated with the expression of resistance to multiple drugs in vitro
57. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
58. Glutathione S-transferases and drug resistance
59. Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170 and 180 kda isoenzymes
60. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4′-(9-acridinylamino)-methanesulfon-m- anisidide
61. A temperature sensitive topoisomerase-II allele confers temperature dependant drug resistance on amsacrine and etoposide-A genetic system for determining the targets of topoisomerase II inhibitors
62. DNA topoisomerasetargeting antitumor drugs can be studied in yeast
63. Catalytic function of DNA topoisomerase II
64. Novel selection and geneticcharacterization of an etoposide- resistant human leukaemic CCRF-CEM cell line
65. Topoisomerase I in multidrug resistance
66. Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors
67. DNA topoisomerases I and II in cancer chemotherapy: update and perspectives
68. A human small cell lung carcinoma cell line, resistante to 4′-(9-acridinylamino)-methanesulfom-m-anisidide and cross resistant to camptothecin with a high level of topoisomerase I
69. No evidence of apoptotic cell death induced by anti-topoisomerase drugs in N417 cells resistant to m-AMSA
70. A type-II DNA topoisomerase and a catenating protein from the transplantable VX2 carcinoma
71. The p53 and mdm-2 genes from human testicular germ tumors
72. Stimulation of the topoisomerase II induced DNA cleavage sites in the c-myc protooncogene by antitumor drugs is associated with gene expression
73. Altered stability of etoposide-induced Topoisomerase II DNA complexes in resistant human leukaemia K562 cells
74. Reduced phosphorylation of topoisomerase II in etoposide resistant human leukemia K562 cells
75. Identification of a mutant human toposiomerase I with intact catalytic activity and resistant to 9-nitro-camptothecin
76. Decreased expression of DNA topoisomerase I in Camptothecin -resistant tumor cell lines as determined by a monoclonal antibody
77. Increased phosphorylation of DNA topoisomearse II in etoposide-resistant mutants of human cancer KB cells
78. DNA topoisomerase- targeting antitumor agents and drug resistance
79. Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerse I and identification of mutation sites
80. Nonproductive rearrangement of DNA topoisomerase I and II genes: Correlation with resistance to topoisomerase inhibitors
81. Cloning of chinese-hamster DNA topoisomerase I cDNA and identification of a singlepoint mutation responsible for camptothecin resistance
82. Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22
83. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes
84. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata
85. DNA topoisomerases
86. Structure and function of type II DNA topoisomerases
87. Proliferation and cell cycledependent differences in expression of the 170 kilodaldon and 180 kilodaldon forms of topoisomerase II in NIH-3T3 cells
88. The genetic regulation of apoptosis